» Articles » PMID: 35902743

Single-nucleus and Spatial Transcriptome Profiling of Pancreatic Cancer Identifies Multicellular Dynamics Associated with Neoadjuvant Treatment

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal and treatment-refractory cancer. Molecular stratification in pancreatic cancer remains rudimentary and does not yet inform clinical management or therapeutic development. Here, we construct a high-resolution molecular landscape of the cellular subtypes and spatial communities that compose PDAC using single-nucleus RNA sequencing and whole-transcriptome digital spatial profiling (DSP) of 43 primary PDAC tumor specimens that either received neoadjuvant therapy or were treatment naive. We uncovered recurrent expression programs across malignant cells and fibroblasts, including a newly identified neural-like progenitor malignant cell program that was enriched after chemotherapy and radiotherapy and associated with poor prognosis in independent cohorts. Integrating spatial and cellular profiles revealed three multicellular communities with distinct contributions from malignant, fibroblast and immune subtypes: classical, squamoid-basaloid and treatment enriched. Our refined molecular and cellular taxonomy can provide a framework for stratification in clinical trials and serve as a roadmap for therapeutic targeting of specific cellular phenotypes and multicellular interactions.

Citing Articles

Spatial Transcriptomics Reveals Novel Mechanisms Involved in Perineural Invasion in Pancreatic Ductal Adenocarcinomas.

Lakis V, Chan N, Lyons R, Blackburn N, Nguyen T, Chang C Cancers (Basel). 2025; 17(5).

PMID: 40075699 PMC: 11899704. DOI: 10.3390/cancers17050852.


Quantifying and interpreting biologically meaningful spatial signatures within tumor microenvironments.

Jing S, Wang H, Lin P, Yuan J, Tang Z, Li H NPJ Precis Oncol. 2025; 9(1):68.

PMID: 40069556 PMC: 11897387. DOI: 10.1038/s41698-025-00857-1.


Analyze the Diversity and Function of Immune Cells in the Tumor Microenvironment From the Perspective of Single-Cell RNA Sequencing.

Ma L, Luan Y, Lu L Cancer Med. 2025; 14(5):e70622.

PMID: 40062730 PMC: 11891933. DOI: 10.1002/cam4.70622.


Development of a prognostic model for hepatocellular carcinoma based on microvascular invasion characteristic genes by spatial transcriptomics sequencing.

Mu X, Pan L, Wang X, Liu C, Li Y, Cai Y Front Immunol. 2025; 16:1529569.

PMID: 40051627 PMC: 11882567. DOI: 10.3389/fimmu.2025.1529569.


An Ocular Gene-Set Expression Library for Heritability Partition and Cell Line Enrichment Analyses.

Hysi P, Hammond C Invest Ophthalmol Vis Sci. 2025; 66(3):11.

PMID: 40042876 PMC: 11892535. DOI: 10.1167/iovs.66.3.11.


References
1.
Versteijne E, van Dam J, Suker M, Janssen Q, Groothuis K, Akkermans-Vogelaar J . Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial. J Clin Oncol. 2022; 40(11):1220-1230. DOI: 10.1200/JCO.21.02233. View

2.
Buttner M, Ostner J, Muller C, Theis F, Schubert B . scCODA is a Bayesian model for compositional single-cell data analysis. Nat Commun. 2021; 12(1):6876. PMC: 8616929. DOI: 10.1038/s41467-021-27150-6. View

3.
Dardenne E, Beltran H, Benelli M, Gayvert K, Berger A, Puca L . N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer. Cancer Cell. 2016; 30(4):563-577. PMC: 5540451. DOI: 10.1016/j.ccell.2016.09.005. View

4.
Harder J, Ihorst G, Heinemann V, Hofheinz R, Moehler M, Buechler P . Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer. Br J Cancer. 2012; 106(6):1033-8. PMC: 3304403. DOI: 10.1038/bjc.2012.18. View

5.
VanDussen K, Sonnek N, Stappenbeck T . L-WRN conditioned medium for gastrointestinal epithelial stem cell culture shows replicable batch-to-batch activity levels across multiple research teams. Stem Cell Res. 2019; 37:101430. PMC: 6579736. DOI: 10.1016/j.scr.2019.101430. View